Dosidal · Singapore
ZINNAT FOR SUSPENSION 125 mg/5 ml
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Singapore |
|---|---|
| Record | sg:authorisation:SIN07013P (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | sg-hsa-licence: SIN07013P |
| Source authority | HSA |
| Read date | 2026-08-07T09:43:28Z |
| authorisation status | listing: Listing of Registered Therapeutic Products registered: True state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page |
| identity | approval_date_as_published: 15/5/1992 atc: J01DC02 country_of_manufacture: UNITED KINGDOM&&AUSTRIA&&CHINA dosage_form: GRANULE, FOR SUSPENSION holder: SANDOZ SINGAPORE PTE. LTD. licence_number: SIN07013P manufacturer: Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations)&&Sandoz GmbH&&Titan Pharmaceutical Co., Ltd. (Guangdong) product: ZINNAT FOR SUSPENSION 125 mg/5 ml route: ORAL strength: 125 mg/5 ml substances: CEFUROXIME AXETIL state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page |
| prescription class | class: prescription forensic_classification: Prescription Only state: current · read 2026-08-07T09:43:28Z · source: Health Sciences Authority (HSA), via data.gov.sg page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53h4OTeoMiRwESmKLWMd4hRvXU9sReM5AnkiOwnIWpxUKKZBxk5aTOcLpHWHG67sy4ucXeGch4AxouLUN1Vzc6xQVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/sg:authorisation:SIN07013P · Same medicine in other markets · Dosidal